Small RNAs growing tall: miRNAs as drug targets in herpesvirus infections

Curr Opin Virol. 2015 Dec:15:41-7. doi: 10.1016/j.coviro.2015.07.010. Epub 2015 Aug 6.

Abstract

Herpesviruses establish life-long latent infections. They can cause severe morbidity and significant mortality particularly in immunocompromised hosts. Several are associated with cancers. Most express large amounts of microRNAs during latent or lytic infection. There is increasing evidence that these small RNA molecules play important roles in many aspects of pathogenesis, including lytic and latent infections, immune evasion and tumorigenesis. Therapies targeting microRNAs have already successfully made it into clinics, for example, to treat hepatitis C virus (HCV) infection. In this review, we will focus on regulatory functions of herpesvirus miRNAs that may be suitable for antiviral intervention.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Herpesviridae / drug effects*
  • Herpesviridae / genetics*
  • Herpesviridae Infections / drug therapy*
  • Herpesviridae Infections / virology
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Molecular Targeted Therapy
  • RNA, Viral / genetics
  • RNA, Viral / metabolism

Substances

  • Antiviral Agents
  • MicroRNAs
  • RNA, Viral